VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization

C Chen Su (Biomedical Pioneering Innovation Center, School of Life Sciences, State Key Laboratory of Gene Function and Modulation Research, Peking University) Z Zhibin Liao J Jie Mo F Furong Liu W Weijian Wang H Haoquan Zhang H Hongwei Zhang (Key Laboratory of Development and Application of Rural Renewable Energy) Y Yachong Liu Y Yonglong Pan H He Zhu X Xiaoping Chen Z Zhanguo Zhang P Peng Zhu B Bixiang Zhang

Article Details

Volume / Issue Vol. 16, Issue 1
Published October 10, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (14)

C

Chen Su

Biomedical Pioneering Innovation Center, School of Life Sciences, State Key Laboratory of Gene Function and Modulation Research, Peking University

Z

Zhibin Liao

J

Jie Mo

F

Furong Liu

W

Weijian Wang

H

Haoquan Zhang

H

Hongwei Zhang

Key Laboratory of Development and Application of Rural Renewable Energy

Y

Yachong Liu

Y

Yonglong Pan

H

He Zhu

X

Xiaoping Chen

Z

Zhanguo Zhang

P

Peng Zhu

B

Bixiang Zhang